Contact

If you have corrections, questions, or feedback about Myelorin's work, we welcome thoughtful input so our independent resource remains accurate and cautious.

For details on editorial methods and how corrections are handled, see our editorial overview on the about page for an explanation of sourcing and independence. To navigate back to the site's main content and resources, use the link to the home collection of articles.

Close-up detail view illustrating microscopic or tissue detail related to ibogaine and multiple sclerosis mechanisms

How to reach Myelorin

Myelorin can be reached through its published channels. At present there is no public email or phone for direct enquiries; please check back here for updates to our contact details and editorial corrections process.

To understand how we handle corrections and editorial decisions before reaching out, visit the site's editorial overview on the about page where our approach and sourcing practices are explained in detail.

If you arrived here from another resource and want to explore related treatment-centre listings, note that Myelorin does not endorse services; for a directory of clinics and programs you may consult external listings such as the treatment center index at ibogaine treatment centers in the US as a separate directory resource.

Myelorin

Myelorin is an independent resource on the emerging science, limits, and safety questions surrounding ibogaine and multiple sclerosis. It distinguishes mechanistic hypotheses from established clinical evidence.